Drug Trial Radar · NCT02727660
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
Last checked: Nov 19, 2026Latest source record: Sep 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,876
Actual
Start
Apr 29, 2016
Primary completion
Apr 4, 2018
Study completion Apr 4, 2018
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 4, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6 μg, all administered BID.
Conditions
- Chronic Obstructive Pulmonary Disorder
Interventions
BFF MDI (PT009) 320/9.6 μgDrug
Blinded Treatment
BFF MDI (PT009) 160/9.6 μgDrug
Blinded Treatment
FF MDI (PT005) 9.6 μgDrug
Blinded Treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Morning Pre-dose Trough FEV1Time frame: at Week 12
Locations
282 sites in 19 countries. Site status is shown where the registry gives one.
Research Site
Dothan, Alabama
Research Site
Huntsville, Alabama
Research Site
Sheffield, Alabama
Research Site
Flagstaff, Arizona
Research Site
Costa Mesa, California
Research Site
Gold River, California
Research Site
Lincoln, California
Research Site
Long Beach, California
Research Site
Palo Alto, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
Upland, California
Research Site
Yorba Linda, California
Research Site
Boulder, Colorado
Research Site
Denver, Colorado
Research Site
New Haven, Connecticut
Research Site
Boynton Beach, Florida
Research Site
Chiefland, Florida
Research Site
Clearwater, Florida
Research Site
Daytona Beach, Florida
Research Site
Hialeah, Florida
Research Site
Kissimmee, Florida
Research Site
Leesburg, Florida
Research Site
Lehigh Acres, Florida
Research Site
Merritt Island, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
Ormond Beach, Florida
Research Site
Port Orange, Florida
Research Site
Sarasota, Florida
Research Site
Tampa, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Atlanta, Georgia
Research Site
Dacula, Georgia
Showing 40 of 282 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.